{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:34:33Z","timestamp":1787009673437,"version":"build-2736575974"},"reference-count":110,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Netherlands Research Council"},{"name":"European Union\u2019s Horizon-MSCA project SIGNATURE","award":["101072891"],"award-info":[{"award-number":["101072891"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Nephrotoxicity is a major concern in the safety assessment of chemicals and drugs. Computational modeling, particularly the use of quantitative adverse outcome pathways (qAOPs), offers a promising strategy to improve the translation from in vitro to in vivo, thereby facilitating reliable predictions of in vivo adverse outcomes and potentially reducing the need for animal testing. Platinum-based drugs are widely used in chemotherapy, yet their clinical application is frequently constrained by nephrotoxic effects. Here, we focus on the development of ordinary differential equation (ODE)-based qAOPs for platinum-induced nephrotoxicity by defining both an in vitro and an in vivo data-driven model. The in vitro model incorporates newly generated, time-course gene expression and propidium iodide (PI) staining data from RPTEC\/TERT1 cells exposed to cisplatin. The in vivo model employs published rat data, including dose-response platinum kinetics as well as single-dose time-course platinum kinetics, gene expression, and histopathology data. Our quantitative approach shows that key processes in the AOP related to immune system activity are nonlinear. Specifically, clearance of necrotic kidney cells by immune system activity counters damage accumulation on a timescale of days, yet low-level inflammation still cumulatively affects kidney failure in the long run. Moreover, we perform quantitative in vitro to in vivo extrapolation (QIVIVE) to link the 2 models. With this approach, in vivo adverse outcome predictions can be made in the future not only for platinum-based compounds but also for the safety assessment of other chemicals and drugs, reducing the need for animal testing.<\/jats:p>","DOI":"10.1093\/toxsci\/kfaf177","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T12:26:52Z","timestamp":1767702412000},"source":"Crossref","is-referenced-by-count":3,"title":["Quantitative adverse outcome pathway modeling of cisplatin-induced nephrotoxicity: developing\n                    <i>in vitro<\/i>\n                    and\n                    <i>in vivo<\/i>\n                    models for predictive extrapolation"],"prefix":"10.1093","volume":"209","author":[{"given":"Filippo","family":"Di Tillio","sequence":"first","affiliation":[{"name":"Leiden Academic Centre for Drug Research, Leiden University Division of Cell Systems and Drug Safety, , Leiden, 2333 CC,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas S","family":"Wijaya","sequence":"additional","affiliation":[{"name":"Leiden Academic Centre for Drug Research, Leiden University Division of Cell Systems and Drug Safety, , Leiden, 2333 CC,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9549-1719","authenticated-orcid":false,"given":"Steven J","family":"Kunnen","sequence":"additional","affiliation":[{"name":"Leiden Academic Centre for Drug Research, Leiden University Division of Cell Systems and Drug Safety, , Leiden, 2333 CC,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl Joshua","family":"Eugenio","sequence":"additional","affiliation":[{"name":"Leiden Academic Centre for Drug Research, Leiden University Division of Cell Systems and Drug Safety, , Leiden, 2333 CC,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0340-8822","authenticated-orcid":false,"given":"Giorgio","family":"Buzzanca","sequence":"additional","affiliation":[{"name":"Department of Pathology, Leiden University Medical Center , Leiden, 2300 RC,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imke B","family":"Bruns","sequence":"additional","affiliation":[{"name":"Leiden Academic Centre for Drug Research, Leiden University Division of Cell Systems and Drug Safety, , Leiden, 2333 CC,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2230-0840","authenticated-orcid":false,"given":"Marvin","family":"Martens","sequence":"additional","affiliation":[{"name":"Department of Translational Genomics, NUTRIM, Maastricht University , Maastricht, 6229 ER,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nynke I","family":"Kramer","sequence":"additional","affiliation":[{"name":"Department of Toxicology, Wageningen University , Wageningen, 6708 WE,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Kers","sequence":"additional","affiliation":[{"name":"Department of Pathology, Leiden University Medical Center , Leiden, 2300 RC,","place":["The Netherlands"]},{"name":"Department of Pathology, Amsterdam UMC, University of Amsterdam , Amsterdam, 1081 HV,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Callegaro","sequence":"additional","affiliation":[{"name":"Leiden Academic Centre for Drug Research, Leiden University Division of Cell Systems and Drug Safety, , Leiden, 2333 CC,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob","family":"van de Water","sequence":"additional","affiliation":[{"name":"Leiden Academic Centre for Drug Research, Leiden University Division of Cell Systems and Drug Safety, , Leiden, 2333 CC,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost B","family":"Beltman","sequence":"additional","affiliation":[{"name":"Leiden Academic Centre for Drug Research, Leiden University Division of Cell Systems and Drug Safety, , Leiden, 2333 CC,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"2026022209370808600_kfaf177-B1","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1021\/acs.chemrestox.6b00341","article-title":"A history of the molecular initiating event","volume":"29","author":"Allen","year":"2016","journal-title":"Chem Res Toxicol"},{"key":"2026022209370808600_kfaf177-B2","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1128\/MCB.01435-12","article-title":"Delineation of the key aspects in the regulation of epithelial monolayer formation","volume":"33","author":"Aschauer","year":"2013","journal-title":"Mol Cell Biol"},{"key":"2026022209370808600_kfaf177-B3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.cbi.2019.05.029","article-title":"Wogonin pre-treatment attenuates cisplatin-induced nephrotoxicity in rats: impact on PPAR-, inflammation, apoptosis and WNT\/-catenin pathway","volume":"308","author":"Badawy, Alaa","year":"2019","journal-title":"Chem Biol Interact"},{"key":"2026022209370808600_kfaf177-B4","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1369\/0022155419852932","article-title":"Renal inflammation and fibrosis: a double-edged sword","volume":"67","author":"Black","year":"2019","journal-title":"J Histochem Cytochem"},{"key":"2026022209370808600_kfaf177-B5","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.3892\/or.10.6.1663","article-title":"Cisplatin and platinum drugs at the molecular level","volume":"10","author":"Boulikas","year":"2003","journal-title":"Oncol Rep"},{"key":"2026022209370808600_kfaf177-B6","doi-asserted-by":"publisher","first-page":"842.e5","DOI":"10.1016\/j.ajem.2010.06.026","article-title":"Carboplatin: a new cause of severe type B lactic acidosis secondary to mitochondrial DNA damage","volume":"29","author":"Brivet","year":"2011","journal-title":"Am J Emerg Med"},{"key":"2026022209370808600_kfaf177-B7","doi-asserted-by":"publisher","first-page":"e1012844","DOI":"10.1371\/journal.pcbi.1012844","article-title":"Computational modelling identifies primary mediators of crosstalk between DNA damage and oxidative stress responses","volume":"21","author":"Burgers, Elsje","year":"2025","journal-title":"PLoS Comput Biol"},{"key":"2026022209370808600_kfaf177-B8","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1007\/s00204-021-03141-w","article-title":"The human hepatocyte TXG-MAPR: gene co-expression network modules to support mechanism-based risk assessment","volume":"95","author":"Callegaro","year":"2021","journal-title":"Arch Toxicol"},{"key":"2026022209370808600_kfaf177-B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v076.i01","article-title":"Stan: a probabilistic programming language","volume":"76","author":"Carpenter","year":"2017","journal-title":"J Stat Softw"},{"key":"2026022209370808600_kfaf177-B10","doi-asserted-by":"publisher","first-page":"20521","DOI":"10.1021\/acs.est.3c07077","article-title":"Acetylcholinesterase inhibition in rats and humans following acute fenitrothion exposure predicted by physiologically based kinetic modeling-facilitated quantitative in vitro to in vivo extrapolation","volume":"57","author":"Chen","year":"2023","journal-title":"Environ Sci Technol"},{"key":"2026022209370808600_kfaf177-B11","doi-asserted-by":"publisher","first-page":"113873","DOI":"10.1016\/j.bcp.2020.113873","article-title":"Inhibition of thioredoxin reductase 1 correlates with platinum-based chemotherapeutic induced tissue injury","volume":"175","author":"Cheng","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"2026022209370808600_kfaf177-B12","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.cmet.2019.08.003","article-title":"Mitochondrial damage and activation of the sting pathway lead to renal inflammation and fibrosis","volume":"30","author":"Chung","year":"2019","journal-title":"Cell Metab"},{"key":"2026022209370808600_kfaf177-B13","doi-asserted-by":"publisher","first-page":"4661","DOI":"10.1021\/acs.est.6b06230","article-title":"Quantitative adverse outcome pathways and their application to predictive toxicology","volume":"51","author":"Conolly","year":"2017","journal-title":"Environ Sci Technol"},{"key":"2026022209370808600_kfaf177-B14","doi-asserted-by":"publisher","first-page":"100330","DOI":"10.1016\/j.comtox.2024.100330","article-title":"Developing quantitative adverse outcome pathways: an ordinary differential equation-based computational framework","volume":"32","author":"Di Tillio","year":"2024","journal-title":"Computational Toxicology"},{"key":"2026022209370808600_kfaf177-B15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1124\/jpet.107.120402","article-title":"Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney","volume":"322","author":"Faubel","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"2026022209370808600_kfaf177-B16","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/clpt.2009.139","article-title":"Contribution of organic cation transporter 2 (Oct2) to cisplatin-induced nephrotoxicity","volume":"86","author":"Filipski","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"2026022209370808600_kfaf177-B17","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3390\/cancers3011351","article-title":"Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects","volume":"3","author":"Florea","year":"2011","journal-title":"Cancers (Basel)"},{"key":"2026022209370808600_kfaf177-B18","doi-asserted-by":"publisher","first-page":"353","DOI":"10.14573\/altex.1810181","article-title":"A modular approach for assembly of quantitative adverse outcome pathways","volume":"36","author":"Foran","year":"2019","journal-title":"ALTEX"},{"key":"2026022209370808600_kfaf177-B19","doi-asserted-by":"publisher","first-page":"153060","DOI":"10.1016\/j.tox.2021.153060","article-title":"Integrating in vitro chemical transplacental passage into a generic PBK model: a qivive approach","volume":"465","author":"Fragki","year":"2022","journal-title":"Toxicology"},{"key":"2026022209370808600_kfaf177-B20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197416","article-title":"Ppar-deletion attenuates cisplatin nephrotoxicity by modulating renal organic transporters mate-1 and oct-2","volume":"21","author":"Freitas-Lima","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026022209370808600_kfaf177-B21","author":"Gabry","year":"2023"},{"key":"2026022209370808600_kfaf177-B22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.tox.2013.08.012","article-title":"Dose metric considerations in in vitro assays to improve quantitative in vitro\u2013in vivo dose extrapolations","volume":"332","author":"Groothuis","year":"2015","journal-title":"Toxicology"},{"key":"2026022209370808600_kfaf177-B23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0093-7754(03)00399-3","article-title":"Oxaliplatin-safety profile: neurotoxicity","volume":"30","author":"Grothey","year":"2003","journal-title":"Semin Oncol"},{"key":"2026022209370808600_kfaf177-B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.fitote.2022.105355","article-title":"Wedelolactone: a molecule of interests","volume":"164","author":"Ha","year":"2023","journal-title":"Fitoterapia"},{"key":"2026022209370808600_kfaf177-B25","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3892\/ijo.16.2.283","article-title":"Assessment of secondary necrosis of Jurkat cells using a new microscopic system and double staining method with annexin V and propidium iodide","volume":"16","author":"Honda","year":"2000","journal-title":"Int J Oncol"},{"key":"2026022209370808600_kfaf177-B26","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1109\/MCSE.2007.55","article-title":"Matplotlib: a 2d graphics environment","volume":"9","author":"Hunter","year":"2007","journal-title":"Comput Sci Eng"},{"key":"2026022209370808600_kfaf177-B27","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.mito.2006.11.026","article-title":"Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage","volume":"7","author":"Indo","year":"2007","journal-title":"Mitochondrion"},{"key":"2026022209370808600_kfaf177-B28","doi-asserted-by":"publisher","first-page":"864441","DOI":"10.3389\/ftox.2022.864441","article-title":"Application of the adverse outcome pathway concept to in vitro nephrotoxicity assessment: kidney injury due to receptormediated endocytosis and lysosomal overload as a case study","volume":"4","author":"Jarzina","year":"2022","journal-title":"Front Toxicol"},{"key":"2026022209370808600_kfaf177-B29","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1084\/jem.194.6.863","article-title":"Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens","volume":"194","author":"Kadowaki","year":"2001","journal-title":"J Exp Med"},{"key":"2026022209370808600_kfaf177-B30","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1515\/CCLM.2003.195","article-title":"Mitochondrial oxidative stress and mitochondrial DNA","volume":"41","author":"Kang","year":"2003","journal-title":"Clin Chem Lab Med"},{"key":"2026022209370808600_kfaf177-B31","doi-asserted-by":"publisher","first-page":"14574","DOI":"10.3390\/ijms241914574","article-title":"Oxidative damage as a fundament of systemic toxicities induced by cisplatin: the crucial limitation or potential therapeutic target?","volume":"24","author":"Katani\u0107 Stankovi\u0107","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026022209370808600_kfaf177-B32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/toxsci\/kfy220","article-title":"Identifying attributes that influence in vitro-to-in vivo concordance by comparing in vitro tox21 bioactivity versus in vivo drugmatrix transcriptomic responses across 130 chemicals","volume":"167","author":"Klaren","year":"2019","journal-title":"Toxicol Sci"},{"key":"2026022209370808600_kfaf177-B33","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s11095-007-9254-z","article-title":"Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications","volume":"24","author":"Koepsell","year":"2007","journal-title":"Pharm Res"},{"key":"2026022209370808600_kfaf177-B34","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S08915849(98)00216-0","article-title":"Mitochondrial damage induced by conditions of oxidative stress","volume":"26","author":"Kowaltowski","year":"1999","journal-title":"Free Radic Biol Med"},{"key":"2026022209370808600_kfaf177-B35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.tiv.2015.09.005","article-title":"Biokinetics in repeated-dosing in vitro drug toxicity studies","volume":"30","author":"Kramer","year":"2015","journal-title":"Toxicol In Vitro"},{"key":"2026022209370808600_kfaf177-B36","doi-asserted-by":"publisher","first-page":"112978","DOI":"10.1016\/j.isci.2025.112978","article-title":"Utilizing rat kidney gene co-expression networks to enhance safety assessment biomarker identification and human translation","volume":"28","author":"Kunnen","year":"2025","journal-title":"iScience"},{"key":"2026022209370808600_kfaf177-B37","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","article-title":"Wgcna: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"2026022209370808600_kfaf177-B38","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.mito.2005.02.002","article-title":"Nuclear and mitochondrial DNA repair: similar pathways?","volume":"5","author":"Larsen","year":"2005","journal-title":"Mitochondrion"},{"key":"2026022209370808600_kfaf177-B39","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1046\/j.1523-1755.1999.00687.x","article-title":"Apoptosis induced by cisplatin nephrotoxic injury","volume":"56","author":"Lau","year":"1999","journal-title":"Kidney Int"},{"key":"2026022209370808600_kfaf177-B40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1155\/1999\/176515","article-title":"Critical evaluation of techniques to detect and measure cell death: study in a model of UV radiation of the leukaemic cell line HL60","volume":"19","author":"Leite","year":"1999","journal-title":"Anal Cell Pathol"},{"key":"2026022209370808600_kfaf177-B41","doi-asserted-by":"publisher","first-page":"F700","DOI":"10.1152\/ajprenal.1996.270.4.F700","article-title":"Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis","volume":"270","author":"Lieberthal","year":"1996","journal-title":"Am J Physiol-Renal Physiol"},{"key":"2026022209370808600_kfaf177-B42","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1681\/ASN.2005060669","article-title":"A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity","volume":"17","author":"Liu","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"2026022209370808600_kfaf177-B43","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/nrneph.2011.149","article-title":"Cellular and molecular mechanisms of renal fibrosis","volume":"7","author":"Liu","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"2026022209370808600_kfaf177-B44","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/sj.ki.5000054","article-title":"Renal fibrosis: new insights into the pathogenesis and therapeutics","volume":"69","author":"Liu","year":"2006","journal-title":"Kidney Int"},{"key":"2026022209370808600_kfaf177-B45","doi-asserted-by":"publisher","author":"Love","year":"2021","DOI":"10.18129\/B9.bioc.DESeq2"},{"key":"2026022209370808600_kfaf177-B46","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/labinvest.2016.60","article-title":"Molecular mechanisms underlying attenuation of cisplatin-induced acute kidney injury by epicatechin gallate","volume":"96","author":"Malik","year":"2016","journal-title":"Lab Invest"},{"key":"2026022209370808600_kfaf177-B47","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1158\/1535-7163.MCT-14-0636","article-title":"Tumor-related molecular mechanisms of oxaliplatin resistance","volume":"14","author":"Martinez-Balibrea","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"2026022209370808600_kfaf177-B48","doi-asserted-by":"publisher","first-page":"e81162","DOI":"10.1371\/journal.pone.0081162","article-title":"Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions","volume":"8","author":"Marullo","year":"2013","journal-title":"PLoS One"},{"key":"2026022209370808600_kfaf177-B49","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrneph.2014.114","article-title":"Inflammatory processes in renal fibrosis","volume":"10","author":"Meng","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"2026022209370808600_kfaf177-B50","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1021\/jm049508t","article-title":"Cytotoxicity of CIS-platinum(II) conjugate models. the effect of chelating arms and leaving groups on cytotoxicity: a quantitative structure-activity relationship approach","volume":"48","author":"Monti","year":"2005","journal-title":"J Med Chem"},{"key":"2026022209370808600_kfaf177-B51","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1208\/s12248-013-9465-7","article-title":"Organic cation transporter octs (SLC22) and mates (SLC47) in the human kidney","volume":"15","author":"Motohashi","year":"2013","journal-title":"AAPS J"},{"key":"2026022209370808600_kfaf177-B52","author":"National Center for Biotechnology Information","year":"2025"},{"key":"2026022209370808600_kfaf177-B53","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1016\/j.celrep.2020.01.108","article-title":"Dissecting the regulatory strategies of NF-\u03baB Rela target genes in the inflammatory response reveals differential transactivation logics","volume":"30","author":"Ngo","year":"2020","journal-title":"Cell Rep"},{"key":"2026022209370808600_kfaf177-B54","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.toxlet.2023.10.001","article-title":"Predicting acute paraquat toxicity using physiologically based kinetic modelling incorporating in vitro active renal excretion via the Oct2 transporter","volume":"388","author":"Noorlander","year":"2023","journal-title":"Toxicol Lett"},{"key":"2026022209370808600_kfaf177-B55","doi-asserted-by":"crossref","first-page":"7848","DOI":"10.1039\/C8DT90088D","article-title":"The side effects of platinum-based chemotherapy drugs: a review for chemists","volume":"47","author":"Oun","year":"2018","journal-title":"Dalton Trans"},{"key":"2026022209370808600_kfaf177-B56","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin nephrotoxicity: mechanisms and renoprotective strategies","volume":"73","author":"Pabla","year":"2008","journal-title":"Kidney Int"},{"key":"2026022209370808600_kfaf177-B57","doi-asserted-by":"publisher","first-page":"6572","DOI":"10.1074\/jbc.M708211200","article-title":"Atr-CHK2 signaling in P53 activation and DNA damage response during cisplatin-induced apoptosis","volume":"283","author":"Pabla","year":"2008","journal-title":"J Biol Chem"},{"key":"2026022209370808600_kfaf177-B58","doi-asserted-by":"publisher","first-page":"100195","DOI":"10.1016\/j.comtox.2021.100195","article-title":"Towards a QAOP framework for predictive toxicology\u2014linking data to decisions","volume":"21","author":"Paini","year":"2022","journal-title":"Comput Toxicol"},{"key":"2026022209370808600_kfaf177-B59","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1124\/jpet.108.147181","article-title":"Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative\/nitrosative stress, inflammation, and cell death","volume":"328","author":"Pan","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"2026022209370808600_kfaf177-B60","doi-asserted-by":"crossref","first-page":"332","DOI":"10.5935\/0101-2800.20130052","article-title":"Acute nephrotoxicity of cisplatin: molecular mechanisms","volume":"35","author":"Peres","year":"2013","journal-title":"J Bras Nefrol"},{"key":"2026022209370808600_kfaf177-B61","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/toxsci\/kfv181","article-title":"Adverse outcome pathways for regulatory applications: examination of four case studies with different degrees of completeness and scientific confidence","volume":"148","author":"Perkins","year":"2015","journal-title":"Toxicol Sci"},{"key":"2026022209370808600_kfaf177-B62","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1002\/etc.4505","article-title":"Building and applying quantitative adverse outcome pathway models for chemical hazard and risk assessment","volume":"38","author":"Perkins","year":"2019","journal-title":"Environ Toxicol Chem"},{"key":"2026022209370808600_kfaf177-B63","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3390\/antiox9080647","article-title":"Mitochondrial dysfunction, oxidative stress, and neuroinflammation: intertwined roads to neurodegeneration","volume":"9","author":"Picca","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"2026022209370808600_kfaf177-B64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2010\/672395","article-title":"Dampening inflammation by modulating TLR signalling","volume":"2010","author":"Piccinini","year":"2010","journal-title":"Mediators Inflamm"},{"key":"2026022209370808600_kfaf177-B65","doi-asserted-by":"publisher","first-page":"105133","DOI":"10.1016\/j.tiv.2021.105133","article-title":"Effective exposure of chemicals in in vitro cell systems: a review of chemical distribution models","volume":"73","author":"Proen\u00e7a","year":"2021","journal-title":"Toxicol In Vitro"},{"key":"2026022209370808600_kfaf177-B66","doi-asserted-by":"publisher","first-page":"XC01","DOI":"10.7860\/JCDR\/2016\/18181.8126","article-title":"Cisplatin concentrations in long and short duration infusion: implications for the optimal time of radiation delivery","volume":"10","author":"Rajkumar","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"2026022209370808600_kfaf177-B67","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1172\/JCI15691","article-title":"Tnf-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity","volume":"110","author":"Ramesh","year":"2002","journal-title":"J Clin Invest"},{"key":"2026022209370808600_kfaf177-B68","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1007\/s001250050752","article-title":"Quantitative morphology of the rat kidney during diabetes mellitus and insulin treatment","volume":"40","author":"Rasch","year":"1997","journal-title":"Diabetologia"},{"key":"2026022209370808600_kfaf177-B69","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/BF01255892","article-title":"Hyperthermia enhances the cytotoxicity and platinum\u2013DNA adduct formation of lobaplatin and oxaliplatin in cultured SW 1573 cells","volume":"123","author":"Rietbroek","year":"1997","journal-title":"J Cancer Res Clin Oncol"},{"key":"2026022209370808600_kfaf177-B70","doi-asserted-by":"publisher","first-page":"e0146021","DOI":"10.1371\/journal.pone.0146021","article-title":"Dose-response analysis using R","volume":"10","author":"Ritz","year":"2015","journal-title":"PLoS One"},{"key":"2026022209370808600_kfaf177-B71","doi-asserted-by":"publisher","first-page":"669379","DOI":"10.3389\/fcell.2021.669379","article-title":"The mitochondrial response to dna damage","volume":"9","author":"Rong","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2026022209370808600_kfaf177-B72","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1097\/TP.0000000000002366","article-title":"A 2018 reference guide to the Banff classification of renal allograft pathology","volume":"102","author":"Roufosse","year":"2018","journal-title":"Transplantation"},{"key":"2026022209370808600_kfaf177-B73","doi-asserted-by":"publisher","first-page":"e105070","DOI":"10.1371\/journal.pone.0105070","article-title":"Ameliorative effect of fisetin on cisplatin-induced nephrotoxicity in rats via modulation of NF-\u03baB activation and antioxidant defence","volume":"9","author":"Sahu","year":"2014","journal-title":"PLoS One"},{"key":"2026022209370808600_kfaf177-B74","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.phymed.2012.12.001","article-title":"Hesperidin attenuates cisplatin-induced acute renal injury by decreasing oxidative stress, inflammation and DNA damage","volume":"20","author":"Sahu","year":"2013","journal-title":"Phytomedicine"},{"key":"2026022209370808600_kfaf177-B75","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.bbrc.2011.06.186","article-title":"Discrimination between primary necrosis and apoptosis by necrostatin-1 in annexin V-positive\/propidium iodide-negative cells","volume":"411","author":"Sawai","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"2026022209370808600_kfaf177-B76","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/pst.426","article-title":"Guidelines for accurate EC50\/IC50 estimation","volume":"10","author":"Sebaugh","year":"2011","journal-title":"Pharm Stat"},{"key":"2026022209370808600_kfaf177-B77","doi-asserted-by":"publisher","author":"Smith","year":"2019","DOI":"10.1093\/nar\/gkz1041"},{"key":"2026022209370808600_kfaf177-B78","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1590\/S1984-82502014000400004","article-title":"Carboplatin: molecular mechanisms of action associated with chemoresistance","volume":"50","author":"Sousa","year":"2014","journal-title":"Braz J Pharm Sci"},{"key":"2026022209370808600_kfaf177-B79","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1007\/s00204-020-02774-7","article-title":"Quantitative adverse outcome pathway (QAOP) models for toxicity prediction","volume":"94","author":"Spinu","year":"2020","journal-title":"Arch Toxicol"},{"key":"2026022209370808600_kfaf177-B80","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1681\/ASN.2011040416","article-title":"Mast cells mediate acute kidney injury through the production of tnf","volume":"22","author":"Summers","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2026022209370808600_kfaf177-B81","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3109\/08923973.2015.1127382","article-title":"TGF-: the connecting link between nephropathy and fibrosis","volume":"38","author":"Sutariya","year":"2016","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"2026022209370808600_kfaf177-B82","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2478\/cipms-2019-0004","article-title":"Effect of tirapazamine on selected kidney parameters in rats treated with cisplatin","volume":"32","author":"Sysa","year":"2019","journal-title":"Curr Issue Pharm Med Sci"},{"key":"2026022209370808600_kfaf177-B83","doi-asserted-by":"publisher","first-page":"4904","DOI":"10.4049\/jimmunol.1000383","article-title":"Endogenous IL-10 attenuates cisplatin nephrotoxicity: role of dendritic cells","volume":"185","author":"Tadagavadi","year":"2010","journal-title":"J Immunol"},{"key":"2026022209370808600_kfaf177-B84","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41581-022-00631-7","article-title":"Cisplatin nephrotoxicity: new insights and therapeutic implications","volume":"19","author":"Tang","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"2026022209370808600_kfaf177-B85","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1146\/annurev-pharmtox-052220-104025","article-title":"Targeting NRF2 and its downstream processes: opportunities and challenges","volume":"62","author":"Torrente","year":"2022","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2026022209370808600_kfaf177-B86","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/minf.201000061","article-title":"Best practices for QSAR model development, validation, and exploitation","volume":"29","author":"Tropsha","year":"2010","journal-title":"Mol Inform"},{"key":"2026022209370808600_kfaf177-B87","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/toxsci\/kfab076","article-title":"Quantitative in vitro-to-in vivo extrapolation for mixtures: a case study of superfund priority list pesticides","volume":"183","author":"Valdiviezo","year":"2021","journal-title":"Toxicol Sci"},{"key":"2026022209370808600_kfaf177-B88","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/sj.bjc.6603606","article-title":"Adaptive dosing and platinum\u2013DNA adduct formation in children receiving highdose carboplatin for the treatment of solid tumours","volume":"96","author":"Veal","year":"2007","journal-title":"Br J Cancer"},{"key":"2026022209370808600_kfaf177-B89","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s11222-016-9696-4","article-title":"Practical Bayesian model evaluation using leave-oneout cross-validation and WAIC","volume":"27","author":"Vehtari","year":"2017","journal-title":"Stat Comput"},{"key":"2026022209370808600_kfaf177-B90","first-page":"3491","author":"Vehtari","year":"2024"},{"key":"2026022209370808600_kfaf177-B91","doi-asserted-by":"publisher","first-page":"105143","DOI":"10.1016\/j.yrtph.2022.105143","article-title":"R-ODAF: omics data analysis framework for regulatory application","volume":"131","author":"Verheijen","year":"2022","journal-title":"Regul Toxicol Pharmacol"},{"key":"2026022209370808600_kfaf177-B92","doi-asserted-by":"publisher","first-page":"242","DOI":"10.2165\/00003088-199121040-00002","article-title":"Clinical pharmacokinetics of carboplatin","volume":"21","author":"Vijgh","year":"1991","journal-title":"Clin Pharmacokinet"},{"key":"2026022209370808600_kfaf177-B93","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/toxsci\/kfu199","article-title":"Adverse outcome pathway (AOP) development I: strategies and principles","volume":"142","author":"Villeneuve","year":"2014","journal-title":"Toxicol Sci"},{"key":"2026022209370808600_kfaf177-B94","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1007\/s00204-017-2020-z","article-title":"Adverse outcome pathways: a concise introduction for toxicologists","volume":"91","author":"Vinken","year":"2017","journal-title":"Arch Toxicol"},{"key":"2026022209370808600_kfaf177-B95","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","article-title":"Scipy 1.0: fundamental algorithms for scientific computing in Python","volume":"17","author":"Virtanen","year":"2020","journal-title":"Nat Methods"},{"key":"2026022209370808600_kfaf177-B96","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12929-019-0518-9","article-title":"Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumur toxicity","volume":"26","author":"Volarevic","year":"2019","journal-title":"J Biomed Sci"},{"key":"2026022209370808600_kfaf177-B97","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3109\/0886022X.2011.577546","article-title":"Effect of curcumin on cisplatin- and oxaliplatin-induced oxidative stress in human embryonic kidney (HEK) 293 cells","volume":"33","author":"Waly","year":"2011","journal-title":"Ren Fail"},{"key":"2026022209370808600_kfaf177-B98","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd1691","article-title":"Cellular processing of platinum anticancer drugs","volume":"4","author":"Wang","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"2026022209370808600_kfaf177-B99","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-023-01347-1","article-title":"Targeting p53 pathways: mechanisms, structures and advances in therapy","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"2026022209370808600_kfaf177-B100","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10565-025-10003-z","article-title":"Spatio-temporal transcriptomic analysis reveals distinct nephrotoxicity, DNA damage, and regeneration response after cisplatin","volume":"41","author":"Wijaya","year":"2025","journal-title":"Cell Biol Toxicol"},{"key":"2026022209370808600_kfaf177-B101","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.tiv.2014.10.006","article-title":"Mechanism of cisplatin proximal tubule toxicity revealed by integrating transcriptomics, proteomics, metabolomics and biokinetics","volume":"30","author":"Wilmes","year":"2015","journal-title":"Toxicol In Vitro"},{"key":"2026022209370808600_kfaf177-B102","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jprot.2012.11.022","article-title":"Application of integrated transcriptomic, proteomic and metabolomic profiling for the delineation of mechanisms of drug induced cell stress","volume":"79","author":"Wilmes","year":"2013","journal-title":"J Proteomics"},{"key":"2026022209370808600_kfaf177-B103","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1073\/pnas.94.2.514","article-title":"Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress","volume":"94","author":"Yakes","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026022209370808600_kfaf177-B104","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/MAJ.0b013e31812dfe1e","article-title":"Cisplatin nephrotoxicity: a review","volume":"334","author":"Yao","year":"2007","journal-title":"Am J Med Sci"},{"key":"2026022209370808600_kfaf177-B105","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3109\/10408444.2012.692115","article-title":"Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results","volume":"42","author":"Yoon","year":"2012","journal-title":"Crit Rev Toxicol"},{"key":"2026022209370808600_kfaf177-B106","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.fct.2015.01.014","article-title":"Cisplatin-induced renal toxicity via tumor necrosis factor-\u03b1, interleukin 6, tumor suppressor P53, DNA damage, xanthine oxidase, histological changes, oxidative stress and nitric oxide in rats: protective effect of ginseng","volume":"78","author":"Yousef","year":"2015","journal-title":"Food Chem Toxicol"},{"key":"2026022209370808600_kfaf177-B107","doi-asserted-by":"publisher","first-page":"F546","DOI":"10.1152\/ajprenal.00072.2006","article-title":"Acute renal failure: determinants and characteristics of the injury-induced hyperinflammatory response","volume":"291","author":"Zager","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026022209370808600_kfaf177-B108","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.7150\/thno.69424","article-title":"Platinum-based drugs for cancer therapy and anti-tumor strategies","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"key":"2026022209370808600_kfaf177-B109","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1007\/s00204015-1633-3","article-title":"DNA damage response in cisplatin-induced nephrotoxicity","volume":"89","author":"Zhu","year":"2015","journal-title":"Arch Toxicol"},{"key":"2026022209370808600_kfaf177-B110","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1134\/S0006297918030045","article-title":"Mechanisms of mitochondrial dna repair in mammals","volume":"83","author":"Zinovkina","year":"2018","journal-title":"Biochemistry (Mosc)"}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/toxsci\/advance-article-pdf\/doi\/10.1093\/toxsci\/kfaf177\/66328410\/kfaf177.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/toxsci\/article-pdf\/209\/2\/kfaf177\/66328410\/kfaf177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/toxsci\/article-pdf\/209\/2\/kfaf177\/66328410\/kfaf177.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T14:37:18Z","timestamp":1771771038000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/toxsci\/article\/doi\/10.1093\/toxsci\/kfaf177\/8418627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":110,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,18]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfaf177","relation":{},"ISSN":["1096-6080","1096-0929"],"issn-type":[{"value":"1096-6080","type":"print"},{"value":"1096-0929","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2026,1,9]]},"article-number":"kfaf177"}}